公司資料
PainReform 股價、新聞與催化劑
- 股票代碼:
- PRFX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Israel and listed in the U
股票表現
0.97 USD (-5.81%)
收盤價
最後更新: 2026年8月17日
1.75M USD
市值
股價為何變動
As of Aug 17, 2026, PRFX closed down 5.81% at $0.9702. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
PainReform is a specialty pharmaceutical company focused on pain management and formulation technology. Its story is built around improving local analgesia through delivery science rather than broad drug discovery.
所在地與產業分類
PainReform is headquartered in Israel and listed in the U.S. market. It sits in specialty pharma and pain management.
商業模式特徵
The company depends on clinical progress, formulation validation, and commercialization strategy. Investors typically watch data, market access, and capital runway.
生技產業定位
PainReform occupies a niche pain-formulation position within healthcare. The stock is driven by whether its delivery platform can matter in a crowded pain market.
未來催化劑
- PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction. The company still needs stronger adoption.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。